Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms beta-NF-JQ1 |
Target |
Action degraders |
Mechanism BRD2 degraders(Bromodomain-containing protein 2 degraders), BRD3 degraders(Bromodomain-containing protein 3 degraders), BRD4 degraders(Bromodomain-containing protein 4 degraders) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC45H42ClN5O6S |
InChIKeyOZFKLXDOAZGVSV-BHVANESWSA-N |
CAS Registry2380000-55-3 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | Japan | 03 Oct 2019 |





